Sid Martin Biotech Incubator ranked world's best for biotech in global benchmarking study
July 23, 2013
GAINESVILLE, Fla. — The University of Florida Sid Martin Biotechnology Incubator was ranked “World’s Best University Biotechnology Incubator,” according to an international study conducted by the Sweden-based research group UBI.
The inaugural benchmarking report was based on an extensive analysis of 150 incubators in 22 countries.
“Being recognized as world’s top biotech incubator is especially gratifying because UBI’s rankings are data-driven,” said incubator director Patti Breedlove.
UBI assessed more than 50 performance indicators including job creation, talent retention, access to funding, network enhancement and post-incubation relationships.
The report found that European incubators perform substantially lower than U.S. programs, despite spending more on operations and client seed funding.
European incubators grant their clients nine times as much seed funding but create 1.9 times fewer jobs and 2.8 times lower revenue per client per year.
Top incubators, like UF Sid Martin Biotech, create 2.8 times more jobs than the global average, according to the study.
“We couldn’t be more proud of the talented team at the Sid Martin Biotech Incubator. With their help, UF is producing an outstanding crop of bioscience companies” said David L. Day, director of UF’s Office of Technology Licensing.
The Texas-based Alliance for Technology and Entrepreneurship was named top global incubator overall. Other top incubators by sector were Ireland’s NDR Launchpad (information technology), and New York’s UB Technology (life sciences).
The full “Top University Business Incubators: Global Benchmark Report 2013” can be downloaded at ubiindex.com
Built in 1995, UF Sid Martin Biotech is one of the U.S.’s first bio-business incubators. The 40,000-square-foot bioscience complex was internationally recognized as the National Business Incubation Association’s 2013 Incubator of the Year. Its companies and graduates have attracted more than $1 billion in equity investment, contracts, grants, and M&A activity.
For more information, contact Patti Breedlove, UF Sid Martin Biotech director, at 386-462-0880 or email@example.com.